LQDA Q4 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+66.7% YoY

Gross Profit

$5M87.1% margin

Operating Income

-$6M-121.2% margin

Net Income

-$7M-121.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+69.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$129M

Total Liabilities

$39M

Stockholders' Equity

$90M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+66.7%
Gross Profit	$5M	$2M	+87.5%
Operating Income	-$6M	-$11M	+42.8%
Net Income	-$7M	-$12M	+43.5%